Adverse events in endoscopic ultrasound-guided choledochoduodenostomy with lumen-apposing metal stents: A systematic review and meta-analysis
- PMID: 38736198
- DOI: 10.1111/jgh.16614
Adverse events in endoscopic ultrasound-guided choledochoduodenostomy with lumen-apposing metal stents: A systematic review and meta-analysis
Abstract
Background and aim: Several meta-analyses have analyzed the technical and clinical success of endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS) by using lumen-apposing metal stents (LAMS) in malignant biliary obstruction, but those concerning adverse events (AEs) are scarce. The current systematic review and meta-analysis was conducted to evaluate the AEs after EUS-CDS with LAMS.
Methods: A comprehensive literature search of PubMed, Embase, Scopus, Web of Science, and the Cochrane Library was conducted for studies reporting the outcomes of EUS-CDS with LAMS. The main endpoints were the incidence of overall and specific AEs. Moreover, the stent dysfunction, and reintervention rates were evaluated independently.
Results: A total of 21 studies (n = 1438) were included in the final meta-analysis. The pooled rate of technical and clinical success was 93.5% (95% confidence interval [CI]: 91.3-95.1) and 88.0% (95% CI: 83.9-91.1), respectively. After EUS-CDS with LAMS, the pooled incidence of overall AEs was 20.1% (95% CI: 16.0-24.9). The estimated rate of early AEs was 10.6% (95% CI: 7.9-14.2), and late AEs was 11.2% (95% CI: 8.2-15.2). Infection/cholangitis was the commonest AE, with a pooled incidence of 6.1% (95% CI: 3.7-10.1). The estimated incidence of stent dysfunction and reintervention was 10.5% (95% CI: 7.5-14.4), and 12.1% (95% CI: 9.3-15.7), respectively.
Conclusion: Despite with a high technical and clinical success rate, EUS-CDS with LAMS may be associated with overall AEs and stent dysfunction in one-fifth and one-tenth of cases, respectively. Further efforts are required to optimize its safety and long-term stent patency.
Keywords: Adverse events; Biliary obstruction; Choledochoduodenostomy; Endoscopic ultrasound; Lumen‐apposing metal stent.
© 2024 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
References
-
- Teoh AYB, Napoleon B, Kunda R et al. EUS‐guided choledocho‐duodenostomy using lumen apposing stent versus ERCP with covered metallic stents in patients with unresectable malignant distal biliary obstruction: a multicenter randomized controlled trial (DRA‐MBO Trial). Gastroenterology 2023; 165: 473–482.
-
- Chen YI, Sahai A, Donatelli G et al. Endoscopic ultrasound‐guided biliary drainage of first intent with a lumen‐apposing metal stent vs. endoscopic retrograde cholangiopancreatography in malignant distal biliary obstruction: a multicenter randomized controlled study (ELEMENT trial). Gastroenterology 2023. https://doi.org/10.1053/j.gastro.2023.07.024.
-
- Ginestet C, Sanglier F, Hummel V et al. EUS‐guided biliary drainage with electrocautery‐enhanced lumen‐apposing metal stent placement should replace PTBD after ERCP failure in patients with distal tumoral biliary obstruction: a large real‐life study. Surg Endosc 2022; 36: 3365–3373.
-
- Mohan BP, Shakhatreh M, Garg R, Ponnada S, Navaneethan U, Adler DG. Efficacy and safety of endoscopic ultrasound‐guided choledochoduodenostomy: a systematic review and meta‐analysis. J Clin Gastroenterol 2019; 53: 243–250.
-
- Krishnamoorthi R, Dasari CS, Thoguluva Chandrasekar V et al. Effectiveness and safety of EUS‐guided choledochoduodenostomy using lumen‐apposing metal stents (LAMS): a systematic review and meta‐analysis. Surg Endosc 2020; 34: 2866–2877.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources